Skip to main content

Lung Function Tests

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Defence Therapeutics
Defence TherapeuticsBC - Vancouver
1 program
Health Effects Following Use of Lead Free Ammunition Used With HK416N/A1 trial
Active Trials
NCT01477645Completed55Est. Mar 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Defence TherapeuticsHealth Effects Following Use of Lead Free Ammunition Used With HK416

Clinical Trials (1)

Total enrollment: 55 patients across 1 trials

NCT01477645Defence TherapeuticsHealth Effects Following Use of Lead Free Ammunition Used With HK416

Health Effects Following Use of Lead Free Ammunition Used With HK416

Start: Nov 2011Est. completion: Mar 201255 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.